Review
Copyright ©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Nov 28, 2006; 12(44): 7097-7103
Published online Nov 28, 2006. doi: 10.3748/wjg.v12.i44.7097
Associations between NOD2/CARD15 genotype and phenotype in Crohn’s disease-Are we there yet?
Graham Radford-Smith, Nirmala Pandeya
Graham Radford-Smith, IBD Unit, Department of Gastroenter-ology, Royal Brisbane and Womens Hospital, Brisbane, Queensland 4029, Australia
Nirmala Pandeya, Cancer and Population studies group, Queensland Institute of Medical Research, Brisbane, Australia
Correspondence to: Graham Radford-Smith, IBD Unit, Department of Gastroenterology, Royal Brisbane and Womens Hospital, Brisbane, Queensland 4029, Australia. grahamr@qimr.edu.au
Telephone: +61-7-36361321 Fax: +61-7-36364336
Received: May 20, 2006
Revised: May 28, 2006
Accepted: June 14, 2006
Published online: November 28, 2006
Abstract

There have been multiple NOD2/CARD15 genotype-phenotype analyses undertaken in patients with Crohn's disease since the gene’s discovery in 2001. This review focuses on the major published series based upon their size and on the presence of specific clinical and genetic information provided in the published material from 2001 to 2005. Twelve studies provided raw data to carry out comparisons of disease location while ten studies included analysis of NOD2/CARD15 genotypes. NOD2/CARD15 variant frequency in ileal disease did not differ significantly among studies, whereas a comparison of disease location demonstrated highly significant differences among studies. Meta-analysis confirmed significant associations between NOD2/CARD15 variants and both ileal and ileocolonic disease locations, and with both stricturing and penetrating forms of disease behavior. This review underlines the significant phenotypic differences that exist among populations, including similar ethnic groups, and has demonstrated the need for further studies of patients with long-term “inflammatory” Crohn’s disease.

Keywords: Crohn’s disease, Phenotypic heterogeneity, Genotype, Inter-observer agreement, Disease location, Disease behavior